Cite
MLA Citation
Kenneth B Gordon et al.. “Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial.” Lancet, vol. 397, no. 10273, 2021, pp. 475–486. http://access.bl.uk/ark:/81055/vdc_100120458003.0x00005a